OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

SUMITOMO PHARMA CO. LTD./  JP3495000006  /

Frankfurt
2024-06-11  8:10:29 AM Chg. 0.0000 Volume Bid8:10:30 AM Ask8:10:30 AM Market Capitalization Dividend Y. P/E Ratio
2.0600EUR 0.00% 0
Turnover: 0.0000		 2.0600Bid Size: 1,300 2.1400Ask Size: 1,200 835.75 mill.EUR - -

Assets

 2022
IFRS
in mill. JPY		 2023
IFRS
in mill. JPY
Property and Equipment
  64,091   58,909
Intangible Assets
  398,692   329,314
Long-Term Investments
  115,395   135,021
Fixed Assets
  808,486   752,882
Inventories
  99,021   94,405
Accounts Receivable
  151,407   95,908
Cash and Cash Equivalents
  202,984   143,478
Current Assets
  499,521   381,860
Total Assets
  1.31 mill.   1.13 mill.

 

Liabilities

 2022
IFRS
in mill. JPY		 2023
IFRS
in mill. JPY
Accounts Payable
  46,183   52,141
Long-term debt
  243,963   244,128
Liabilities to Banks
  -   -
Provisions
  145,699   155,588
Liabilities
  634,438   727,960
Share Capital
  22,400   22,400
Total Equity
  607,888   406,749
Minority Interests
  65,681   33
Total liabilities equity
  1.31 mill.   1.13 mill.

 

Income Statement

 2022
IFRS
in mill. JPY		 2023
IFRS
in mill. JPY
Revenues
  560,035   555,544
Depreciation (total)
  38,348   41,263
Operating Result
  60,234   -76,979
Interest Income
  22,727   29,059
Income Before Taxes
  -   -
Income Taxes
  42,361   48,794
Minority Interests Profit
  -15,813   22,202
Net Income
  56,413   -74,512

 

Per Share

 2022
IFRS
in JPY		 2023
IFRS
in JPY
Earnings per Share
  141.9900   -187.5500
Dividend per Share
  28.0000   28.0000

 

Cash Flow

 2022
IFRS
in mill. JPY		 2023
IFRS
in mill. JPY
Cash Flow from Operating Activities
  31,239   11,937
Cash Flow from Investing Activities
  -18,278   52,419
Cash Flow from Financing
  -21,426   -146,817
Decrease / Increase in Cash
  -   -
Employees
  6,987   6,250